Introduction
Over the last few decades, tailored epilepsy surgery has successively replaced standard lobectomies. This development was enabled by the availability of 1.5-and 3-Tesla magnetic resonance imaging (MRI), which enables the detection of epileptogenic lesions and their demarcation against nonlesional tissue. The significance of epileptogenic lesions is indicated by the fact that incomplete resection is usually associated with poor outcome. 1 It is less clear, however, in which cases epileptogenic lesions as visualised by MRI, and the epileptogenic zone (EZ) as defined by Lü ders, 2 overlap completely, and when circumscribed lesionectomy or destruction is sufficient for seizure control. The study of small bottomof-sulcus focal-cortical dysplasias (FCD) type IIB could help elucidate this. 3 According to intralesional electroencephalography (EEG), these are intrinsically epileptogenic, 4 and limited resections concentrating on the cortical aspect of the lesions suffice for seizure freedom.
Purpose: Over the last few decades, preferred epilepsy surgical approaches have developed from standard lobectomies to individually tailored resections. Yet, it remains uncertain how small surgical interventions can be without compromising the success of the surgery. Particularly in patients with epileptogenic lesions identified by magnetic resonance imaging (MRI), it is unresolved whether resection or destruction of the lesion suffices to eliminate the epileptogenic zone. We present a minimally invasive surgical approach that may provide insight into this issue. Methods: Two patients with pharmacoresistant epilepsy due to focal cortical dysplasia type IIB demonstrated by 3 Tesla MRI were treated with lesion-focused stereotactic radio-frequency thermocoagulation. In both patients, pathognomonic epileptic discharges were recorded from the lesion via a stimulation device prior to coagulation. In one patient, the suspected proximity of the lesion to the pyramidal tract was verified by eliciting motor evoked potentials from the depths of the lesion. Results: Following complete and near complete lesion destruction, seizures (several per day or per week, respectively) ceased in patients A and B, with no seizures for 12 months and 5 months, respectively, at the time of this publication. Neither patient acquired persistent postoperative neurological deficits.
Conclusion:
The fact that seizure activity stopped after destruction of small bottom-of-sulcus dysplasias implies that in these cases, the epileptogenic zone and the epileptogenic lesion may overlap. If future studies can replicate this finding, focused lesion destruction could be a further development of individually tailored epilepsy surgery. The technique described here is especially suited for highprecision surgery close to eloquent brain structures. ß 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Abbreviations: EEG, electroencephalography; EZ, epileptogenic zone; FCD IIB, focal cortical dysplasia type IIB; RFTC, radio-frequency thermo-coagulation; MRI, magnetic resonance imaging; 3D-FLAIR, three dimensionally acquired fluid attenuated inversion recovery MRI sequence.
Patients and methods
A 39-year-old (patient A) and a 46-year-old patient (patient B) suffered from epilepsy with several seizures per day (patient A) and per week (patient B) despite pharmacological treatment for 30 and 28 years. In both patients, 3 Tesla MRI including a three dimensional 1 mm Â 1 mm Â 1 mm fluid-attenuated inversion recovery (3D-FLAIR) sequence showed the typical signs of singular, circumscribed FCD IIB. Both lesions were identified as being epileptogenic lesions by non-invasive presurgical workup. For clinical details see Table 1 .
An extended lesionectomy was offered to each patient with an estimated chance for long term seizure freedom of 80% but a significant risk of permanent neurological morbidity. In patient A, the lesion was located in the right pre-central gyrus close to the neocortical face representation. More importantly, the deep parts of the lesion reached the pyramidal tract ( Fig. 1(A1) ); therefore, the risk of paresis following resection was estimated at 50%. In patient B, the left fronto-orbital lesion did not immediately neighbour eloquent cortex or fibre tracts ( Fig. 1(B1) ), but complications during an open sub-frontal surgical approach could have resulted in aphasic disturbance.
The patients were informed about alternative local lesion destruction via stereotactic RFTC. Based on clinical and in vivo data relating the dimensions of tissue defects to the applied electrode type, temperature and heating time, 7, 8 together with the large clinical experience from the application of this technology for functional stereotactic neurosurgery (thalamotomy, pallidotomy), the procedural risk was estimated to be lower than that of conventional surgery. Experience regarding the chances for seizure freedom following lesion-oriented RFTC was lacking. However, for the case of complete lesion destruction, a similar chance for seizure freedom as for the case of lesionectomy was projected. Both patients opted for the RFTC. RFTC was planned based on the lesion extent recognisable on 3 Tesla 3D-FLAIR, coregistered to a contrast enhanced 3D-T1 to prevent penetration of blood vessels by the electrode. For the definition of coagulation points and trajectories, we used treatment planning software (Praezis-Plus, Precisis AG, Walldorf, Germany) developed for stereotactic brachytherapy of intracerebral tumours with iodine-125 seeds. 9 Relying on the known volume and shape of ablated tissue resulting from heating (80 8C for 60 s = 60 mm 3 ) with a bipolar radio frequency probe (TCB013, Inomed, Freiburg, Germany), partially overlapping coagulation sites were planned to ablate the lesions. Because of the complex lesion anatomy, six and seven trajectories for patients A and B, respectively, via four 8 mm burr-holes were necessary ( Fig. 1(A2) and (B2)). RFTC was performed under general anaesthesia. A stimulation electrode was inserted via a Riechert-Mundiger frame (TA, Precisis AG, Walldorf, Germany). Epileptogenicity of the lesions was verified at all planned coagulation sites and at additional sites within the trajectories by bipolar 1 channel EEG via the contacts at the macroelectrode tip ( Fig. 1(A3) ). In both patients, FCD-typical repetitive spikes were detected within the lesion.
In patient A, motor evoked potentials (MEP) were elicited via the probe (Fig. 1(A4) ) at sites that were suspected to be close to the pyramidal tract. At one site, electrical stimulation triggered a typical seizure with left periorbital jerks. At 7 sites, electrical stimulation elicited motor function, documented by MEP-electrodes and by visual inspection (2Â left thumb; 7Â left chin/mouth). EEG and MEP were recorded with an XLTEK 32 IOM system (Natus Medical, San Carlos, CA).
RFTC was finally performed at 16 (patient A, Fig. 1(A5) ) and 14 (patient B) sites using a 500 kHz radiofrequency generator (NeuroN50, Inomed, Freiburg, Germany). In both patients, only minor modifications from the original plan were made: (i) one and two additional coagulation sites were added for patients A and B, respectively, within the planned trajectories because of intense epileptic discharge activity; (ii) in patient A two existing trajectories were extended forward by 4.8 and 3 mm because of intense epileptic activity at the planned deepest position; (iii) also in patient A, in one trajectory all three planned stimulation sites were shifted forward by 3 mm. Four coagulations were performed in patient A despite proof of motor function because of prominent epileptic discharges (three occurrences of a chin motor response, one occurrence of mouth and discrete thumb activity at high stimulation intensities -interpreted as remote activation).
Results
Focal necroses resulting from the RFTC-procedures are shown in Fig. 1(A6) and (B3). At three months, the coagulation sites are surrounded by a slight non-space-occupying oedema. One year after the intervention (patient A), a persisting cerebro-spinal fluid iso-intense substance defect remains. Coregistration of the preand postoperative MRI indicates complete (patient A), and almost complete (patient B), destruction of the deep cortical and directly subcortical FLAIR-signal intensity attributed to the FCD IIB. As intended, the transmantle sign was left unaffected in both cases. In patient A, the superficial cortical layers over the former FCD have been maintained. The neighbouring sulcus, including its vessels, remained intact.
In both patients, the preoperative seizure activity ceased. Patient A (preoperatively 4-5 seizures per day) reported two unprovoked seizures of atypical semiology compared to her preoperative ones on post-operative days 56 and 57. Since these events, she has been completely seizure free for 12 months despite a self-initiated tapering of her preoperative medication from 450 mg to 125 phenytoin/day (last measured phenytoin blood level: 1.7 mg/ml). Patient B (seizures almost every other night, preoperatively) has had no seizures since surgery (5 months). He has not yet significantly tapered the medication.
Following intervention, patient A had a transient mild paresis of the left corner of her mouth (as expected from intraoperative stimulation), but at no time did she have paresis of the hand. Patient B had no neurological deficit.
Discussion
These first two cases of strongly lesion-focused RFTC are significant for two reasons. First, these cases provide evidence that in a subset of epileptogenic lesions, the EZ may not exceed the MRIvisible lesion and that lesion-oriented RFTC is a suitable surgical tool to address this issue. Furthermore, they illustrate that RFTC is a high precision surgical technique that can be applied close to eloquent structures.
The overlap of epileptogenic lesions and the EZ is not selfevident. Invasive EEG often shows interictal and ictal epileptic discharge patterns that exceed the lesional area. These suggest that epileptogenicity extends beyond the visible lesion margins. 4 However, epileptic discharges beyond lesion limits could be due to propagation effects outside that area that must be resected for seizure freedom. Their significance can only be determined by very lesion-focused surgical strategies. We hope that our report will stimulate further investigations to determine the effectiveness of lesion destruction in eliminating seizure activity. This would be a significant further development of the concept of individually tailored epilepsy surgery and could contribute to the discussion of what the EZ/what-to-remove area is.
Small bottom-of-sulcus FCD IIB is a good candidate lesion entity with which to begin research. Resections limited to the neocortical lesion aspect achieve seizure freedom in >80% of the patients even when the lesion extension towards the ventricle (transmantle sign) remains in place. 5 Detailed analysis of the coagulation defect in patient A indicates that the RFTC left a small rim of superficial, non-lesional cortical layers intact over the lesion. Even this did not preclude 12 months of seizure freedom despite a phenytoin blood level that was close to zero at the last follow up visit. This observation is suggestive of a restricted EZ within the FLAIR-signal intense FCD. The significance of the two atypical seizures on days 56 and 57 remains unclear. Possibly, these seizures are not predictive of failure to achieve long-term seizure freedom, just as a transient increase in simple-partial seizures following temporomesial radio-therapy is believed to be non-prognostic. In patient B, we cannot judge with certainty from the 2 month post-operative MRI whether a part of the deep FLAIR-signal intensity has been missed by RFTC ( Fig. 1(B3) , upper panel). This will become evident from the 1 year post-operative MRI. Nevertheless, 5 months after surgery, this patient is completely seizure free. For lesion entities other than small bottom-of-sulcus FCD IIB, RFTC should be performed only after careful consideration of its limitations. RFTC does not supply tissue for histopathology. Therefore, lesions with questionable dignity in the MRI should preferably undergo resective surgery. For lesion entities for which narrow lesionectomies usually do not lead to seizure freedom and for lesions without clearly recognisable margins in MRI (including more diffuse FCD), RFTC may also not be suited. The maximum degree of morphological lesion complexity to which RFTC can be applied and the maximum possible coagulation volume still needs to be evaluated. We have applied up to 16 coagulation sites, destroying approximately 1.5 cm 3 of tissue. For larger lesions, a multi-stage procedure is possible in theory, even a combination of RFTC and open resection. The risk for procedure-associated haemorrhage is low due to the implementation of a contrastenhanced 3D-T1 data set into the planning software. The danger of damaging vessels by focal heating (i.e., in the depth of sulci) is understood to be negligible because of the cooling effects of circulation.
An emerging strength of stereotactic RFTC is its high precision in brain areas where conventional resection would carry a significant risk for persistent neurological deficits. This observation has been made before by other groups who applied stereotactic RFTC to hypothalamic hamartomas 10 and periventricular nodular heterotopia.
11
The volume-of-destruction achieved by RFTC can be anticipated reliably. Commercially available brachytherapy software allows the planning of complex three-dimensional ablations. The elective situation of preoperative planning facilitates the integrating of multimodal imaging information. During surgery, the validity of presurgical assumptions regarding the epileptogenicity of the lesion and the proximity or distance to eloquent structures can be determined via the very electrode that is subsequently used for coagulation. This feedback is an advantage of RFTC over other destructive surgical techniques such as stereotactic radiosurgery. 12 Another advantage over radiosurgery is that the lesions are immediately destroyed without significant oedema.
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